This week at our Pittsburgh, PA, hospital, we are enrolling dogs with a diagnosis of lymphoma for a study evaluating a new chemotherapy approach for treatment. To participate in the study, dogs should be more than one year of age and have a diagnosis of B or T cell lymphoma (stages II, III or IV). Learn more about the study and eligibility: https://lnkd.in/e_wqbEHC. #BluePearlScience #ClinicalStudies #ElevatingVetMed
BluePearl Pet Hospital’s Post
More Relevant Posts
-
MSAT Scientist I Personalized Medicine I Ai/ML| hiPSCs stem cells | Analytics & QC | cGMP | Cell & Gene Therapy | CAR-T ♋I CAR-T | ImmunoTherapy | Gene editing CRISPR🧬✂️ #CAR-T🔬🦠🩸🫁🫀|
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma https://lnkd.in/gjd3ZHwj
-
-
Master the skills of effective communication and collaboration with this Clinical Case Challenge! | Employing Collaborative Care Strategies for the Management of Pediatric Patients With Hodgkin Lymphoma | 0.25-hour CME/CE | Case #2 of 2 https://bit.ly/3qx9992
-
-
Master the skills of effective communication and collaboration with this Clinical Case Challenge! | Employing Collaborative Care Strategies for the Management of Pediatric Patients With Hodgkin Lymphoma | 0.25-hour CME/CE | Case #2 of 2 https://bit.ly/3qx9992
-
-
Lymph nodes in dogs are an important part of their immune system. Unfortunately, dogs can develop lymphoma, which is cancer of the lymph nodes. To catch and possibly prevent this from occurring, it is important to check your dog’s lymph nodes once a month. Find out how to do it: https://lnkd.in/giQQcERv #CheckYourDog #lymphnodesindogs #doglymphnodes #dogimmunesystem #doghealth #NationalCanineCancerFoundation #WeAreTheCure #PinkPaw #NCCF #dogcancer #CanineCancer
-
-
Discover Follicular Lymphoma Prognosis! Explore the FLIPI1 & FLIPI2 tools, your essential guides for assessing Follicular Lymphoma prognosis. FLIPI1: Perfect for the pre-Rituximab era FLIPI2: Tailored for the Rituximab era Try them today: https://lnkd.in/gjYWZs8r #BloodCancerAwarenessMonth #BloodCancer #LymphomaAwareness #HaemBytes #HaemTools
-
Classic, ALK-DUSp22-, TP63- primary cutaneous anaplastic large cell lymphoma https://lnkd.in/dprhVkWp
-
-
In our library of Positive Quality Interventions (PQIs) - precise and concise peer-reviewed clinical guidance resources - you’ll find the 'Initiating Mosunetuzumab-axgb in Relapsed/Refractory Follicular Lymphoma' PQI. This resource provides insights on bispecific T-cell engagement, patient selection, and preventing adverse events during administration in relapsed/refractory follicular lymphoma after two or more lines of systemic therapy. Click the link below to enhance your clinical knowledge: https://bit.ly/492LRJv
-
-
#MantleCellLymphoma, both in its classical and leukemic, non-nodal forms, is an important differential diagnosis for patients with CD5-expressing lymphomas. How do you differentiate #MCL in patients with CD5-expressing lymphomas?
-
